Potaba 500 mg
Images for reference only. Packaging will vary.
Ask A Pharmacist
Please feel free to ask our pharmacists any questions about Potaba.
250 capsules for $135.95 ($0.54 per capsule)
Potaba from online pharmacy: Canada
Potaba 500 mg is available from our online pharmacy for less money than you'd spend locally. If you like the convenience of ordering from your home, you can order your prescription online, or speak with one of our customer service representatives on the phone. Call us, The Drug Company, toll free at 1-888-254-3038. Prior to taking Potaba 500 mg, please consult with your doctor or health professional to see if this medication is right for you. Many customers have saved even more money by speaking with their doctor about a generic substitute.
Why is Potaba prescribed?
Potaba is prescribed for conditions such as scleroderma, dermatomyositis, morphea and linear scleroderma, and Peyronie's disease. It is believed to produce a skin/plaque softening in patients when given in adequate dosage over sufficient time.
How does Potaba work?
Understanding of drug mechanisms at the cellular level is incomplete in the case of many medications. It is thought that Potaba has an antifibrotic effect due to increased oxygen uptake at the tissue level.
How is Potaba administered?
Orally, according to the following schedule:
Potaba Capsules (0.5 g): Take 6 capsules with a glass of water after meals and at bedtime with a snack.
Potaba Powder Envules (2 g/pack): Add 1½ envules to a glass of chilled water or juice; stir to dissolve, and drink after eating.
Potaba Tablets (0.5 g): Crush tablets and add to a glass of chilled water or juice; stir thoroughly and drink after eating.
If you are unable to eat, omit dosage until you resume eating again.
Medication burnout is a term used to describe a situation in which the patient stops taking medication. In consequence, the desired results of therapy will not be seen. Changing dosage form may prevent medication burnout.
What is the advantage of taking Potaba?
Therapy with Potaba is a nontoxic, low-risk treatment for conditions that are usually long-term. This regimen represents a good possibility of softening hardened tissue. As there is a very low incidence of drug interactions, many other medications may be continued while you are taking Potaba. It is highly soluble in water and therefore readily absorbed.
Where can I get Potaba?
Potaba requires a physician's prescription. It can be obtained from your local pharmacy.
Are there any contraindications to Potaba?
Your doctor should know if you are taking antimicrobial sulfonamides as Potaba may nullify the antibacterial effect.
Potaba should be administered with caution in the following medical conditions:
diabetes mellitus (sugar diabetes);
hypoglycemia (chronic low blood sugar);
allergy to Potaba or PABA; and
How long should I take Potaba? How soon will I see results?
Length of therapy varies considerably with disease state and from person to person. It may be 2 to 3 months before results are noticeable.
Are there foods, drink, or activities I should avoid while taking Potaba?
Potaba therapy is most acceptable when taken in conjunction with meals or snacks. There are no specific foods or drinks to avoid, but it is good to keep a normal dietary intake to prevent stomach upset or low blood sugar. The doctor should know if you are on a special diet. Usual activities can be encouraged. If you are pregnant, planning to become pregnant, or nursing an infant, your doctor should be notified so this can be taken into consideration when prescribing Potaba or any prescription medication.
Are there any side effects for Potaba?
Anorexia, nausea, fever and rash have occurred rarely.
What should I do if these symptoms occur?
Notify the doctor, stop taking Potaba until symptoms subside. The doctor may then write a schedule to accomplish densensitization and to resume therapy.
Information for the Patient
Peyronie's disease. Scleroderma. Dermatomyositis. Morphea and linear scleroderma.
Should anorexia or nausea occur, therapy is interrupted until the patient is eating normally again. This permits prompt subsidence of symptoms and also avoids the possible development of hypoglycemia. Give cautiously to patients with renal disease. If a hypersensitivity reaction should occur, aminobenzoate should be stopped.
Each capsule contains: aminobenzoate potassium USP 500 mg. Nonmedicinal ingredients: magnesium stearate NF, microcrystalline cellulose NF, povidone USP, silica gel NF, sodium starch glycolate NF, stearic acid NF. Bottles of 250 and 1 000.
Each tablet contains: aminobenzoate potassium USP 500 mg. Nonmedicinal ingredients: magnesium stearate NF, microcrystalline cellulose NF, povidone USP, silica gel NF, sodium starch glycolate NF, stearic acid NF. Bottles of 100 and 1 000.
Store in a cool place and in well-closed containers.
Each envule contains: aminobenzoate potassium USP 2 g. Nonmedicinal ingredients: magnesium stearate NF, microcrystalline cellulose NF, povidone USP, silica gel NF, sodium starch glycolate NF, stearic acid NF. Boxes of 50.
Patients taking sulfonamides.
Safety for use during lactation has not been established.
Safety for use in pregnancy has not been established.
Anorexia, nausea, fever and rash have occurred infrequently and subside with omission of the drug. Desensitization can be accomplished and treatment resumed.
For management of a suspected drug overdose, CPhA recommends that you contact your regional Poison Control Centre. See the eCPS Directories section for a list of Poison Control Centres.
No data supplied by the manufacturer.
Adults: 12 g given in 4 divided doses.
Tablets and capsules are given at the rate of 6 tablets or capsules 4 times daily, usually with meals, and at bedtime with a snack. Tablets must be crushed and taken with an adequate amount of liquid to prevent gastrointestinal upset.
Envules each contain 2 g of pure drug, and constitute the individual average dose. Six envules are given for a total of 12 g daily.